ImmunityBio IBRX is trying to turn a persistent bottleneck in bladder cancer care into a durable demand driver. The long-running U.S. Bacillus Calmette-Guérin (BCG) shortage has created a structural “pull” for regimens that can improve treatment availability and keep patients on schedule. That backdrop matters because Anktiva plus BCG is already the company’s commercial engine ...
Key Points Humanoid robots — along with fully driverless vehicles — are one of the Next Big Things in artificial intelligence (AI). At this early stage, no publicly traded company seems to be generating significant revenue from the sale of humanoid robots or components used to make them. So, investors might want to spread their ...
Everybody loves semiconductors right now. AI is booming, ’s flying, and FOMO is everywhere. Please watch Sister Semiconductors and Mish as they talk about and teach you how to Not buy the hype… and instead, read the map. One of the biggest mistakes investors make is chasing stocks when they’re already stretched far above support and key moving averages. That’s when risk ...
Key Points Amazon generates higher total revenue than Microsoft, though the latter demonstrates a much smoother and more consistent baseline growth pattern. Amazon experiences distinct quarter-over-quarter revenue spikes during its fourth-quarter periods, while Microsoft maintains a steady, uninterrupted upward trajectory across all evaluated quarters. Investors should carefully watch whether the wide absolute revenue gap between ...
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, CrowdStrike Holdings Inc (Symbol: CRWD) has taken over the #72 spot from Netflix Inc (Symbol: NFLX), according to ETF Channel. Below is a chart of CrowdStrike Holdings Inc versus Netflix Inc plotting their respective rank within the ...
This “Convergence Trigger” stock is still in the early innings of the AI power buildout. Tom Yeung here with your Sunday Digest. Last week here, we talked about how master trader Jonathan Rose and Wall Street veteran Marc Chaikin had combined their smart money indicators into a “Convergence Trigger” signal. They revealed their system’s top five picks in their Convergence Summit on Thursday night. I hope you ...
Over the past month, shares of U.S. legacy automaker Ford F and electric vehicle tech giant Tesla TSLA have rallied more than 23% and 15%, respectively, outperforming the industry. Despite weakening vehicle sales in the country amid affordability concerns, the expiration of federal electric vehicle tax credits and supply chain issues, Ford and Tesla shares ...
The $2 billion the government just deployed tells you exactly which layer of the market wins first Listen to the audio version of this article (generated by AI). What happens when two governments both reach for their checkbooks in the same week, and both bet on the factories, not the machines? On May 21, the ...
Key Points The Chinese company’s AI growth is already visible. It has a built-in capital supply with its e-commerce business. That creates a better risk-reward profile than many high-profile AI stocks. 10 stocks we like better than Alibaba Group › Artificial intelligence (AI) has become one of the market’s most powerful themes. But many of ...
ImmunityBio IBRX is building a portfolio of immunotherapies designed to activate both innate and adaptive immunity in cancer and infectious diseases. Its Cancer BioShield platform centers on Anktiva (nogapendekin alfa inbakicept), an interleukin-15 receptor superagonist antibody-cytokine fusion protein built to stimulate natural killer cells, cytotoxic T cells and memory T cells. With a vertically integrated ...
